John Haurum

John Haurum is an accomplished leader in the biotechnology and pharmaceutical industries, currently serving as a Board Member at Saniona and holding multiple chair positions, including Chair of the Board of Directors at SOLID Therapeutics and Adcendo. Haurum has extensive experience as a strategic advisor, evidenced by the role as Scientific and Biotech Strategy Advisor at Cumulus Oncology. A notable background includes board memberships at NeoPhore Ltd, Synklino, CatalYm GmbH, AgomAb Therapeutics, STORM Therapeutics Limited, and previously at Synact Pharma ApS. Academic credentials include a D.Phil. in Immunology from the University of Oxford and both an MD and M.Sc. in Immunology from Aarhus University.